WASHINGTON—President Donald Trump signed executive orders on April 2 raising levies on some medications and refining calculations on steel tariffs.
Pharmaceutical drugs produced outside the United States are subject to 100 percent tariffs, unless manufacturers agree to onshore production and offer most-favored-nation pricing.





